Login
$COLL
$25.43 +$0.11 (0.43%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
VIKRAM KARNANI Also a director
President and Chief Executive Officer
51 Not stated 2024 $1,715,846
COLLEEN TUPPER
Executive Vice President and Chief Financial Officer
50 Since 2021
5 years
2021 $3,515,055
DAVID DIETER
Executive Vice President, General Counsel and Corporate Secretary
62 Not stated 2025 $3,870,092

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
0 of 1
stated in the proxy; 7 not stated
Average tenure
7.2 years
from year joined
CEO also chairs the board
No
Gino Santini
Director Age On board Independent Committees Other public boards 2025 pay Source
Gino Santini
69 2012
14 years
Not stated
Compensation Transaction
Compass Pathways PLC $400,963
Vikram Karnani
51 2024
2 years
Not independent None stated Dyne Therapeutics, Inc. Paid as CEO
Rita Balice-Gordon
65 2020
6 years
Not stated
Nominating and Corporate Governance Transaction
H. Lundbeck A/S Not stated
Garen Bohlin
78 2015
11 years
Not stated
Audit · Chair Compliance
Karyopharm Therapeutics, Inc. $366,639
John Freund
72 2014
12 years
Not stated
Compensation · Chair Audit
SI-Bone, Inc. $367,268
Nancy Lurker
68 2025
1 year
Not stated
Compliance · Chair Compensation
EyePoint Pharmaceuticals, Inc., Alkermes plc $743,776
Carlos Paya
67 2025
1 year
Not stated
Transaction · Chair Nominating and Corporate Governance
Vaxcyte, Inc. Not stated
John Fallon Leaving at the meeting
Not stated 2015
11 years
Not stated None stated None stated $366,268
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 7, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support